Hamilton Thorne Ltd
XTSX:HTL
Relative Value
The Relative Value of one HTL stock under the Base Case scenario is 1.26 CAD. Compared to the current market price of 1.45 CAD, Hamilton Thorne Ltd is Overvalued by 13%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
HTL Competitors Multiples
Hamilton Thorne Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Hamilton Thorne Ltd
XTSX:HTL
|
212.4m CAD | 2.5 | 216.5 | 30.5 | 182 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.7B USD | 4.6 | 32.6 | 19.2 | 28.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
134B USD | 18.3 | 67.4 | 55.3 | 69.3 | ||
US |
Stryker Corp
NYSE:SYK
|
124.3B USD | 5.9 | 37 | 24 | 29.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | 25.6 | 13.6 | 19.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.2 | 59.8 | 30.5 | 45 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.4B USD | 3.6 | 57 | 19 | 40.2 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.7B EUR | 2.6 | 38 | 18.3 | 30.8 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.2B USD | 13.2 | 78.5 | 58.6 | 76.4 |